Reports and Outcomes

UPDATED: Female Breast Cancer in South Dakota

The SD Department of Health and SD Cancer Registry are pleased to announce the release of the 2026 Female Breast Cancer in South Dakota Monograph.

Female breast cancer is the most common cancer diagnosed among women in South Dakota. In 2026 approximately 860 women will receive a diagnosis of invasive breast cancer in South Dakota, and 90 women will die from the disease.

The monograph is available on the SD Cancer Registry website for download and available to order from the SD Dept. of Health Educational Materials Catalog.

2023 Breast Cancer Monograph

Sun Safety Practices in South Dakota Child Care Settings

Skin cancer is the most commonly diagnosed preventable cancer in the United States. One bad sunburn in childhood doubles the risk of skin cancer later in life. The South Dakota Department of Health partnered with child care programs to support implementation of sun safety policies and evidence-based sun safety interventions to reduce the burden of skin cancer.

Clinical Trial Accrual in South Dakota (2013-2020)

The SD Cancer Plan promotes implementation of policy and system changes to expand equitable access to and promotion of participation in cancer clinical trials which will ultimately help optimize quality of life for cancer patients and survivors in South Dakota.

Trends in Clinical Trial Accrual Rate, Overall and by Treatment Specific Studies, South Dakota, 2013-2020

The enrollment of cancer patients into clinical trial studies is crucial for the development of new cancer treatments and advancements in cancer prevention. Cancer-related clinical research study categories include treatment trials, prevention, screening, and quality-of-life/supportive care/palliative care trials, among others.¹ Priority 10 of the 2021-2025 South Dakota Cancer Plan aims to increase participation of South Dakota (SD) cancer patients in cancer clinical trials. To measure progress, the SD Cancer Coalition partnered with the South Dakota Cancer Registry (SDCR) to determine the current clinical trial accrual rate within South Dakota using a reporting collection template that aligns with Commission on Cancer Standard 1.9: Clinical Research Accrual²to streamline reporting efforts for the cancer treatment centers. Reporting measures included the annual analytic caseload, total number of patients accrued as well as accrual by trial type, and the locations for each trial type (onsite and/or referred). The SDCR utilized this template to request data from the eight cancer treatment centers within the state. Since 2015, the cancer treatment centers have voluntarily reported their data annually to the SDCR. The SDCR assured the hospital-based cancer registries that the reporting was voluntary, and that individual hospital-based data would be held in confidence, with only aggregate data shared. The first report, published in Fall 2019, included data for calendar years 2013 to 2016. This report features data from 2017 to 2020 in addition to the previous years. All eight cancer treatment centers reported the data for a 100% response rate. In addition, click here to view the interactive dashboard.

A summary of the findings presented in the dashboard is described in the article. View full article here.

Cancer Survivorship in South Dakota

The Cancer Survivorship in South Dakota report uses data from the Behavioral Risk Factor Surveillance System (BRFSS) with survey years 2018, 2019, and 2020 to analyze population demographics, cancer type, health status, quality of life, and other relevant indicators among adult cancer survivors. Key findings in the report include:

7.8% of survey respondents reported being diagnosed with cancer, and of those, 18.1% reported having two or more types of cancer
48.5% of survivors received their first cancer diagnosis between the ages of
40-64
Breast cancer was the most prevalent cancer type (21.1%), followed by male reproductive cancers (18.1%), gastrointestinal cancers (12.3%), and female reproductive cancers (11.3%)
Survivors had a higher prevalence of self-reported fair or poor health than those with no cancer history (31.6% vs. 12.4%)

View the full report.

Development of a Survivorship Program at Monument Health Cancer Care Institute

Monument Health Cancer Institute implemented evidence-based patient navigation, survivorship care plans, and referral services to impact the quality of life for cancer survivors. Monument Health Cancer Institute established a survivorship navigation and SCP process and workflow, SCP template, and SCP data tracking mechanism. The facility also established and provided cancer survivor referrals for psychosocial support and rehabilitation services. Additionally, a referral process was established for the Better Choices, Better Health SD Cancer: Thriving and Surviving program. Monument Health provided SCPs to 41% of all eligible patients. Read the